These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19543842)

  • 21. Mesenchymal stromal cells.
    Bernardo ME; Locatelli F; Fibbe WE
    Ann N Y Acad Sci; 2009 Sep; 1176():101-17. PubMed ID: 19796238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow-derived mesenchymal stem cells as immunosuppressants in liver transplantation: a review of current data.
    Zhang H; Chen Z; Bie P
    Transfus Med Rev; 2012 Apr; 26(2):129-41. PubMed ID: 22015073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential of mesenchymal stem cells for the therapy of autoimmune diseases.
    Pistoia V; Raffaghello L
    Expert Rev Clin Immunol; 2010 Mar; 6(2):211-8. PubMed ID: 20402384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants.
    Khan MA; Alanazi F; Ahmed HA; Shamma T; Kelly K; Hammad MA; Alawad AO; Assiri AM; Broering DC
    Stem Cell Res Ther; 2019 Sep; 10(1):290. PubMed ID: 31547869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal Stromal Cells in Solid Organ Transplantation.
    Vandermeulen M; Erpicum P; Weekers L; Briquet A; Lechanteur C; Detry O; Beguin Y; Jouret F
    Transplantation; 2020 May; 104(5):923-936. PubMed ID: 31929427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool.
    García-Castro J; Trigueros C; Madrenas J; Pérez-Simón JA; Rodriguez R; Menendez P
    J Cell Mol Med; 2008 Dec; 12(6B):2552-65. PubMed ID: 19210755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lentivirus-mediated IL-10-expressing Bone Marrow Mesenchymal Stem Cells promote corneal allograft survival
    Lu X; Ru Y; Chu C; Lv Y; Gao Y; Jia Z; Huang Y; Zhang Y; Zhao S
    Theranostics; 2020; 10(18):8446-8467. PubMed ID: 32724480
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mesenchymal stem cells and the immune system--immunosuppression without drugs?].
    Kiss J; Urbán VS; Dudics V; Vas V; Uher F
    Orv Hetil; 2008 Feb; 149(8):339-46. PubMed ID: 18281229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?
    Griffin MD; Ryan AE; Alagesan S; Lohan P; Treacy O; Ritter T
    Immunol Cell Biol; 2013 Jan; 91(1):40-51. PubMed ID: 23207278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Research Status of Mesenchymal Stem Cells in Liver Transplantation.
    You Y; Wen DG; Gong JP; Liu ZJ
    Cell Transplant; 2019 Dec; 28(12):1490-1506. PubMed ID: 31512503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilization of Mesenchymal Stem Cells in Kidney Transplantation: From Bench to Bedside.
    Saidi RF; Moghadasali R; Shekarchian S
    Iran J Kidney Dis; 2019 Jul; 13(4):213-224. PubMed ID: 31422386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation.
    Ball LM; Bernardo ME; Roelofs H; Lankester A; Cometa A; Egeler RM; Locatelli F; Fibbe WE
    Blood; 2007 Oct; 110(7):2764-7. PubMed ID: 17638847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulatory properties of mesenchymal stromal cells.
    Nauta AJ; Fibbe WE
    Blood; 2007 Nov; 110(10):3499-506. PubMed ID: 17664353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9.
    Ding Y; Xu D; Feng G; Bushell A; Muschel RJ; Wood KJ
    Diabetes; 2009 Aug; 58(8):1797-806. PubMed ID: 19509016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppressive properties of mesenchymal stem cells.
    Abumaree M; Al Jumah M; Pace RA; Kalionis B
    Stem Cell Rev Rep; 2012 Jun; 8(2):375-92. PubMed ID: 21892603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem cell therapy for degenerative inflammatory disorders.
    Müller I; Lymperi S; Dazzi F
    Curr Opin Organ Transplant; 2008 Dec; 13(6):639-44. PubMed ID: 19060556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo.
    Lynch K; Treacy O; Chen X; Murphy N; Lohan P; Islam MN; Donohoe E; Griffin MD; Watson L; McLoughlin S; O'Malley G; Ryan AE; Ritter T
    Mol Ther; 2020 Sep; 28(9):2023-2043. PubMed ID: 32531237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming Growth Factor-β Partially Reversed the Immunosuppressive Effect of Mesenchymal Stem Cells in Mice.
    Zhao J; Qi YJ; Wang X; Jiao Y; Gong HM; Zhang JX; Jiang DY
    Transplant Proc; 2018 Dec; 50(10):3851-3857. PubMed ID: 30577277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune properties of mesenchymal stem cells.
    Sotiropoulou PA; Papamichail M
    Methods Mol Biol; 2007; 407():225-43. PubMed ID: 18453259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput RNA-sequencing identifies mesenchymal stem cell-induced immunological signature in a rat model of corneal allograft rejection.
    Lu X; Chu C; Liu X; Gao Y; Wu M; Guo F; Li Y; Geng C; Huang Y; Zhang Y; Zhao S
    PLoS One; 2019; 14(9):e0222515. PubMed ID: 31545822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.